Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-20-022241

CFO and Treasurer sold 1,428 shares at $19.48 ($27,817)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Krognes Steve E. CFO and Treasurer 2020-03-30 Sale −1,428 $19.48 $27,817 1,006,488 D
Open-market sales · 1,428 sh · avg $19.48 · $27,817
Loading xslF345X03/doc4.xml…